Deprescribing and Its Application to Psychiatry
Deprescribing is gaining increasing traction in psychiatry to address the complications and risks of polypharmacy as well as to honor the preferences of the person in treatment. From a recovery-oriented perspective, deprescribing is an opportunity to empower the patient in a shared decision-making process around decreasing the use of psychiatric medication. Yet this process should be carefully thought through, in order to limit negative effects while also respecting a person’s preferences. This chapter reviews indications for considering deprescribing, management of withdrawal effects and increases in symptoms, psychosocial interventions that may be helpful, and strategies for supporting the patient in the decision-making process. Finally, the future directions of deprescribing as a comprehensive intervention are discussed.
KeywordsDeprescribing Psychopharmacology Shared decision-making Recovery-oriented care
- 2.Boghossian TA, Rashid FJ, Thompson W, Welch V, Moayyedi P, Rojas-Fernandez C, et al. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database of Systematic Reviews 2017, Issue 3. Art. No.: CD011969. https://doi.org/10.1002/14651858.CD011969.pub2.
- 13.American Psychiatric Association. American Psychiatric Association Practice Guidelines for the treatment of psychiatric disorders: compendium 2006; 2006. American Psychiatric Pub.Google Scholar
- 17.American Psychiatric Association. Clinical practice guidelines: treatment of schizophrenia. Can J Psychiatr. 2005;50(13):7S.Google Scholar
- 26.Copeland ME. Wellness recovery action plan. Brattleboro: Peach Press; 1997.Google Scholar
- 30.Delano L. 2017. https://withdrawal.theinnercompass.org/. Accessed 14 Feb 2018.
- 31.Hall W. 2012. http://www.willhall.net/files/ComingOffPsychDrugsHarmReductGuide2Edonline.pdf. Accessed 14 Feb 2018.